Eman Kamal Ahmed Abdelall | Biological Network | Best Researcher Award

Published on by Network Science

Dr. Eman Kamal Ahmed Abdelall | Biological Network | Best Researcher Award

Beni-Suef University | Egypt

Dr. Eman Kamal Ahmed Abdelall is a distinguished Professor of Pharmaceutical Organic Chemistry at Beni-Suef University, Egypt, with an outstanding academic and research career spanning over three decades. She earned her Ph.D. in Pharmaceutical Organic Chemistry from Cairo University in 2006 and has since advanced through academic ranks to become a full professor in 2018. Dr. Abdelall has held several key administrative positions, including Vice Dean of Student Affairs and Vice Dean for Environmental Affairs, and currently serves as the Head of the Department of Pharmaceutical Organic Chemistry. A prolific researcher, she has published over 53 peer-reviewed papers in leading journals indexed in Scopus and Google Scholar, with notable contributions to anti-inflammatory, anticancer, and antiviral drug design. Her excellence in scientific research has earned her numerous university honors, medals of excellence, and funded research awards. Dr. Abdelall is also an active reviewer for international journals, a member of higher education promotion committees, and a mentor who has supervised multiple Master’s and Doctoral theses, making her a leading figure in Egypt’s pharmaceutical research community.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Molecular docking, ADME study, Cardiovascular biomarkers and gastric safety of new pyrazoles as selective anti-inflammatory agents", EKA Abdelall, SS Zaghlool, JZF Saad, JN Philoppes, Journal of Molecular Structur, 2025.

"Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities", EKA Abdelall, HAH Elshemy, MB Labib, JN Philoppes, FEM Ali, Bioorganic Chemistry, 2025.

"Synthesis and in silico studies of Novel thiophene–celecoxib hybrid with excellent cardiotoxicity and nephrotoxicity safety profiles", EKA Abdelall, PF Lamie, MB Labib, M El-Daly, A Mishrif, European Journal of Medicinal Chemistry, 2025.

"Novel quinoxaline derivatives as promising cytotoxic agents: structure-based design, in silico studies, VEGFR-2 inhibition, and PI3K/AKT/mTOR pathway modulation", EKA Abdelall, HAH Elshemy, H Abdelmegeed, N Ryad, AA Abdelaziz, Bioorganic Chemistr, 2025.

"The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya", ASH Alhomri, AA Battah, AA Elberry, EKA Abdelall, R Hussein", Pharmacy Practice, 2024.

Nurulhasanah Othman | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Nurulhasanah Othman | Technological Networks | Best Researcher Award

University of Science | Malaysia

Dr. Nurulhasanah Othman is a distinguished researcher recognized for her extensive contributions in the fields of molecular parasitology, proteomics, and infectious disease research. As a Principal Investigator and Co-Researcher on numerous national and university-funded projects, her work reflects a deep commitment to advancing biomedical science and public health. She currently leads a national grant project under the Ministry of Education Malaysia (Kementerian Pendidikan Malaysia) focusing on elucidating the potential inhibitory roles of dextromethorphan and azathioprine targeting Rho GTPase to combat metronidazole-resistant E. histolytica HM1-IMSS (MTZR). Her collaborative projects span a range of innovative studies, including comparative proteome profiling in cervical cancer tissues, identification of immunogenic proteins in G. duodenalis, exploration of antibody profiles in Strongyloides stercoralis, and the development of novel multiplex qPCR assays for triple-negative breast cancer markers. Dr. Nurulhasanah has also served as the Principal Investigator for multiple University Sains Malaysia (USM) research grants, including investigations into pyrethroid resistance in Aedes aegypti, proteomic analyses of Entamoeba histolytica for vaccine development, and protein detection studies using MALDI-TOF/TOF technology. As a Co-Researcher, she has contributed to large-scale genome projects, such as the genomic and proteomic analyses of Malaysian mangrove crab species and horseshoe crabs, as well as molecular diagnostic assay development for Leptospira spp. detection. Through her leadership and interdisciplinary collaborations, Dr. Nurulhasanah has made significant strides in proteomic-based pathogen research, genomic studies, and the pursuit of novel molecular tools for disease control and therapeutic innovation.

Profiles: Orcid ID | Scopus

Featured Publications

"Application of Proteomics to the Study of the Therapeutics and Pathogenicity of Giardia duodenalis"

"Entamoeba histolytica: Membrane and Non-Membrane Protein Structure, Function, Immune Response Interaction, and Vaccine Development"

"A Review: Natural and Synthetic Compounds Targeting Entamoeba histolytica and Its Biological Membrane"

"Evaluation of Total Female and Male Aedes aegypti Proteomes Reveals Significant Predictive Protein–Protein Interactions, Functional Ontologies, and Differentially Abundant Proteins"

"Entamoeba histolytica: Proteomics Bioinformatics Reveal Predictive Functions and Protein–Protein Interactions of Differentially Abundant Membrane and Cytosolic Proteins"